🇺🇸

US SEC Filing Intelligence

· daily

US Executive Officer Management Changes SEC — May 22, 2026

The 47 filings from May 22, 2026, reveal a heavy concentration on annual meeting outcomes and director/officer transitions, with a notable undercurrent of shareholder dissent on equity plan amendments and governance proposals. While most director elections passed with strong support, several companies (Wayfair, Travelers, Investar, Babcock & Wilcox) saw significant opposition (15-26%) to equity plan increases, signaling investor fatigue with dilution. A key trend is the formalization of CFO/executive departures with structured transition agreements (Nerdy, VPG, Neuronetics), often including consulting periods and severance, suggesting companies are prioritizing orderly successions. Insider activity was limited, but the appointment of Jeff Miller (Halliburton CEO) to Noble Corp's board is a high-conviction signal for the offshore drilling sector. Capital allocation trends were mixed: SS&C announced a $1.5B buyback and dividend, while First Busey and LyondellBasell expanded repurchase programs, contrasting with the general focus on equity plan amendments. The most critical development is the high level of 'against' votes on compensation and equity plans, which could pressure boards to reform pay practices. Overall, the data suggests a cautious but active governance environment, with investors closely scrutinizing management incentives and capital use.

47 high priority 47 total filings
· daily

US Corporate Board Director Changes SEC Filings — May 22, 2026

The 46 filings from May 22, 2026, reveal a busy annual meeting season with significant board and executive changes across sectors. A key theme is notable shareholder dissent on equity plan amendments and director elections, with several companies (Investar, Travelers, Babcock & Wilcox) seeing 19-27% opposition on share issuances, signaling potential governance concerns. Insider activity is mixed: positive signals from Nine Energy's permanent CFO appointment and Noble Corp's addition of Halliburton's CEO, offset by three simultaneous director resignations at Tempest Therapeutics and a CFO departure at Nerdy. Capital allocation trends show strong shareholder returns, with SS&C Technologies announcing a $1.5B buyback and LyondellBasell a 10% share repurchase authorization. Sector-wise, financials and energy companies are actively managing board composition, while tech firms face higher scrutiny on compensation plans. The data suggests investors should focus on companies with high opposition rates on governance proposals as potential activism targets, while monitoring insider movements for leadership stability signals.

46 high priority 46 total filings
· daily

US Merger & Acquisition SEC Filings — May 22, 2026

The May 22, 2026, SEC filings reveal a market dominated by SPAC activity, with four IPOs (Iron Dome, Berto, Patriot, Peace) raising a combined $685.1 million and two SPACs (Cayson, Range) seeking shareholder approval to extend their business combination deadlines, indicating a bifurcated market where well-capitalized new SPACs launch while existing ones struggle to find targets. The real estate sector shows active portfolio repositioning: Ashford Hospitality Trust sold a hotel for $37.2M to reduce debt, Generation Income Properties divested a single-tenant retail property for $2.96M, and Armada Hoffler Properties executed a massive $485M multifamily sale to accelerate deleveraging toward a 5.5x-6.5x net debt/EBITDA target. A notable period-over-period trend is the significant accumulated deficits among newly public SPACs—Iron Dome ($8.5M), Patriot ($5.4M)—highlighting the structural costs of going public before operations begin. Insider activity is limited but notable: the Cayson Acquisition insiders continue to fund monthly $125K trust deposits to extend the deal timeline, signaling commitment to finding a target. Forward-looking data points to a catalyst-rich calendar with Range Capital's June 18 shareholder meeting and multiple SPAC unit separations on May 28. The most critical development is Armada Hoffler's $485M portfolio sale, which provides a clear deleveraging catalyst and signals strong institutional demand for multifamily assets.

12 high priority 12 total filings
· monthly

US Pre-Market SEC Filings Roundup — May 22, 2026

This batch of 50 SEC filings, dominated by overnight submissions ahead of the US market open, reveals a clear bifurcation between established operators delivering steady results (Take-Two, Vodafone, Dominion/NextEra merger) and a cohort of micro-cap and distressed companies facing severe liquidity and going-concern risks (Transuite, Trutankless, Allied Gaming). Period-over-period trends highlight a mixed picture: revenue growth is evident in selective names like Trutankless (+347% YoY) and Take-Two (+18.2% YoY), while margin compression and widening losses plague others (Allied Gaming G&A surged 132.7% YoY, Booz Allen revenue fell 6% YoY). The most critical development is the Dominion Energy-NextEra merger, a $2.24B termination-fee deal facing complex regulatory hurdles, and the terminated Estée Lauder/Puig talks, which reset sector M&A expectations. Notable insider and capital allocation activity is sparse, with the primary signals coming from IPO filings (Hyperliquid, Medline, Xanadu Quantum) and SPAC extensions (Tribeca, AmperCap, Cayson), indicating continued appetite for new issuance despite market uncertainty. A significant risk cluster emerges around Nasdaq non-compliance and filing delays (Allied Gaming, Comscore director's former employer bankruptcy), while the handful of positive catalysts—Starfighters Space $17.5M investment, GameStop's performance award tied to EBITDA/market cap—offer selective alpha opportunities. Overall, the digest points to a 'quality vs. junk' divergence where investors should favor companies with strong cash flows (Booz Allen $1.04B OCF, Take-Two positive FCF) and avoid deeply distressed micro-caps with minimal cash and negative working capital.

25 high priority 25 medium 50 total filings
· daily

New Federal Contractors — May 21, 2026

This digest covers five civilian government contracts totaling $755.9 million, all awarded by non-Defense agencies, with zero defense-related exposure. The dominant theme is Health and Human Services (HHS) spending, accounting for four of five contracts and $685.3 million (91%) of total obligation, led by a $432.5 million Leidos Biomedical Research NIH facility operations award. The highest-conviction signal is Peraton Inc.'s $95.1 million CMS Fraud Prevention System 2 win, reflecting durable political support for healthcare fraud IT. A key risk is the August 2024 expiration of SOFTRAMS LLC's $80.7 million CMS IT contract, creating a potential revenue cliff for that small business. Overall, the digest signals stable, multi-year civilian IT and R&D spending, but with low margin upside due to cost-plus and fixed-price structures, and no defense sector catalysts.

5 total filings
· daily

Significant Contract Modifications ($10M+) — May 21, 2026

This digest covers $755.9 million in total obligations across five civilian agency contracts, with zero defense-related awards. The Department of Health and Human Services (HHS) dominates, accounting for four of five contracts and $685.3 million (91% of total value), led by a $432.5 million Leidos Biomedical Research GOCO facility operations award from NIH. The highest-conviction signal is Leidos' stable, multi-year cost-plus revenue stream, though only $1.15 million has been outlaid to date, signaling early-stage execution risk. A key watch item is the August 2024 expiration of SOFTRAMS LLC's $80.7 million CMS IT contract, which creates a potential revenue cliff for that small business. General Dynamics Information Technology's $70.6 million initial obligation on a $1.25 billion ceiling GSA IT contract provides long-term visibility but faces full-and-open competition pressure. No bearish signals were identified, but neutral ratings on three contracts reflect pricing risk, expiration cliffs, or minimal actual revenue recognition.

5 total filings
· daily

Contract Deobligations Alert — May 21, 2026

This digest covers $755.9 million in total obligations across 5 civilian agency contracts, with zero defense-related awards. The Department of Health and Human Services (HHS) dominates, accounting for $685.3 million (90.7%) of the total, led by a $432.5 million NIH GOCO facility operations contract to Leidos Biomedical Research and a $95.1 million CMS fraud prevention system award to Peraton. The highest-conviction signal is Leidos' stable, multi-year NIH revenue stream, though only $1.15 million has been outlayed to date, indicating early-stage execution risk. A key watch item is SOFTRAMS LLC's $80.7 million CMS IT contract expiring in August 2024, creating a potential revenue cliff for the small business. Overall, the digest reflects steady civilian IT and R&D spending but lacks the growth catalysts typical of defense contracts.

5 total filings
· daily

Contract Option Exercises — May 21, 2026

This digest covers $755.9 million in total obligations across 5 civilian contract actions, with zero defense-related awards, underscoring a concentrated non-DOD procurement theme. The dominant agency is the Department of Health and Human Services (HHS), accounting for 90.7% of total value via NIH, CMS, and BARDA awards. The highest-conviction signal is Leidos Biomedical Research's $432.5 million GOCO facility contract with NIH, providing a stable, multi-year revenue stream albeit with cost-plus margin constraints. A key risk is the upcoming August 2024 expiration of SOFTRAMS LLC's $80.7 million CMS IT contract, creating a potential revenue cliff for that small business. Overall, the digest points to steady civilian IT and life sciences R&D spending, but lacks the growth catalysts or margin upside typical of defense contracts.

5 total filings
· daily

Federal IT & Cybersecurity Contracts — May 21, 2026

This digest covers $246.4 million in total obligations across three civilian federal IT contracts, with zero defense-related awards. The dominant theme is healthcare IT modernization and fraud prevention at the Centers for Medicare and Medicaid Services (CMS), which accounts for $175.7 million (71%) of the total. The highest-conviction signal is Peraton Inc.'s $95.1 million Fraud Prevention System 2 award, a time-and-materials contract that provides stable, recurring revenue through 2026-2027 in a politically supported area. A key risk is SOFTRAMS LLC's $80.7 million contract expiring in August 2024, creating a potential revenue cliff if not renewed or recompeted.

3 total filings
· daily

All HHS Contracts — May 21, 2026

This digest covers $685.3 million in HHS contract obligations from May 21, 2026, with zero defense exposure, underscoring a pure civilian healthcare IT and life sciences R&D theme. The dominant signal is a $432.5 million Leidos Biomedical Research GOCO facility contract with NIH, representing 63% of total value and providing stable, multi-year cost-plus revenue. A $95.1 million Peraton fraud prevention contract with CMS adds a high-conviction, politically supported IT growth play. Key risks include a $80.7 million SOFTRAMS HUBZone contract expiring August 2024 (revenue cliff) and a $77.1 million Chimerix BARDA contract that was largely unfunded, highlighting execution risk. The highest-conviction signal is Peraton's CMS Fraud Prevention System 2 award, given CMS's sustained focus on fraud reduction and the time-and-materials pricing flexibility.

4 total filings
· daily

Mega Contracts Monitor ($100M+) — May 21, 2026

This single-contract digest covers a $432.5 million civilian award from the National Institutes of Health (NIH) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., representing the entirety of the period's activity. The contract is a cost-plus-fixed-fee delivery order to operate a government-owned, contractor-operated (GOCO) R&D facility, signaling stable but margin-constrained revenue for Leidos. With zero defense-related awards, the digest highlights a pure civilian R&D services theme, contrasting with typical defense-heavy contract flows. The highest-conviction signal is the low pricing risk and multi-year duration through May 2026, though only $1.15 million has been outlayed to date, creating execution pace uncertainty. A key risk is the early-stage outlay rate, which must accelerate to realize the full $432.5 million value.

1 total filings
· daily

High-Value Federal Grants ($5M+) — May 21, 2026

This digest covers $755.9 million in high-value federal grants and contracts, all from civilian agencies (0% defense), with the Department of Health and Human Services (HHS) as the dominant buyer accounting for $685.3 million (90.7%) of the total. The highest-conviction signal is Leidos Biomedical Research's $432.5 million NIH GOCO facility contract, offering a stable, multi-year cost-plus revenue stream, though early-stage outlay (only $1.15M funded) warrants monitoring. A key risk is the upcoming expiration of SOFTRAMS LLC's $80.7 million CMS IT contract in August 2024, creating a potential revenue cliff for the small business. The digest reveals a civilian IT and life sciences R&D theme, with no defense exposure, and a mix of cost-plus and fixed-price structures that balance margin stability against execution risk.

5 total filings
· daily

General Federal Contracts — May 21, 2026

This digest covers $755.9 million in total obligations across 5 civilian contracts (0 defense-related), with the Department of Health and Human Services (HHS) as the dominant agency, accounting for $684.6 million (90.6%) of the total. The highest-conviction signal is Leidos Biomedical Research's $432.5 million NIH GOCO facility contract, providing a stable, multi-year revenue stream with low pricing risk. However, the digest reveals a key risk: two contracts (SOFTRAMS LLC and Chimerix) face near-term expiration or have minimal outlays, creating potential revenue cliffs or execution uncertainty. The absence of defense contracts underscores a civilian-heavy procurement environment, with HHS life sciences and IT modernization as the dominant sector themes. Investors should watch Peraton's CMS fraud prevention contract for expansion options and GDIT's EMITS 2 for option exercises as key catalysts.

5 total filings
· daily

S&P 500 Technology Sector SEC Filings — May 21, 2026

The 25 filings reveal a bifurcated landscape. The dominant theme is the landmark $52B merger-of-equals between **AvalonBay (AVB)** and **Equity Residential (EQR)**, generating $125M in net synergies and creating the largest multifamily REIT. However, the sheer volume of 8 related filings signals both heightened management attention and potential shareholder skepticism, warranting close monitoring. Separately, **Applied Materials (AMAT)** posted exceptional results with net income up 45.5% YoY and EPS of $6.05, demonstrating robust semi-equipment demand, though operating cash flow growth lagged. At the other extreme, **Apple iSports Group** remains cash-negative with zero revenue and a widening deficit, a clear distress case. **Zoom Communications** showed a mixed picture: revenue grew 5.5% YoY and AI-user uptake surged 184%, but churn ticked up to 3.0%. Capital allocation patterns are split—Radian issued $8M in sign-on equity for a new CEO, while PSBD extended buybacks, and AMAT slowed repurchases sharply to $737M from $3.0B. Overall, the Technology sector shows pockets of strong operational momentum (AMAT, Zoom) alongside significant restructuring and capital reallocation events, creating actionable divergence.

16 high priority 9 medium 25 total filings
· daily

Nasdaq 100 Stocks SEC Filings — May 21, 2026

The 28 filings for the NASDAQ-100 intelligence stream are dominated by the landmark AvalonBay-Equity Residential merger of equals, a $69B transaction that reshapes the multifamily REIT landscape and signals a sector-wide push for scale amid a maturing market. Outside this mega-deal, the data reveals a stark divergence in corporate health: Applied Materials posted exceptional 45.5% net income growth, while Apple iSports Group faces a liquidity crisis with zero revenue and a near-zero cash balance. Capital allocation trends are mixed, with Alphabet tapping the yen bond market for $5.3B and Sun Communities divesting UK assets for $1.03B to refocus on North America. Insider activity is notably absent across most filings, but several companies show strong shareholder support for governance proposals. The period-over-period data highlights a clear 'barbell' market, where cash-rich tech giants and distressed micro-caps coexist, demanding a selective investment approach.

18 high priority 10 medium 28 total filings
· daily

S&P 500 Financials Sector SEC Filings — May 21, 2026

The 50 filings for the S&P 500 Financials sector on May 21, 2026, reveal a sector bifurcated between those executing strategic transformations and those facing acute liquidity stress. The most dominant theme is a wave of corporate restructuring, headlined by the $69 billion AvalonBay-Equity Residential merger of equals—the largest multifamily REIT combination ever—which signals a drive for scale and $175M in projected synergies. On capital allocation, we see contrasting patterns: Deere & Co. maintained a steady $4.5-5.0B guidance despite a 39% profit collapse in Production & Ag, while Shoe Carnival swung to a GAAP loss from $13.6M in transition charges. Period-over-period data shows 5 of the 8 operating companies with revenue or net income comparisons experienced declines or flat results, with Barnwell Industries posting a 29% revenue drop and a 184% cash burn increase. A cluster of 14 Puerto Rico closed-end funds announced strategic reviews to merge into open-end structures, indicating a sector-wide push for liquidity solutions. Insider and governance activity was notable: Rocket Pharmaceuticals saw 31.8% of votes withheld from a director, and Medallion Financial is in a proxy fight while boasting record earnings. Cash positions are eroding at smaller firms—Dalrada Financial saw cash plunge 52% to $82.6K—while larger entities like Cognizant accessed a $1B revolver. The overall picture is one of defensive positioning and portfolio optimization, with management teams acting decisively to address structural challenges.

27 high priority 23 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — May 21, 2026

The 50 filings from the S&P 500 Consumer Staples sector reveal a sector bifurcating between scale-driven leaders and challenged players. Walmart's strong Q1 FY27 (revenue +7.3% YoY, eCommerce +26%) contrasts with a sharp negative free cash flow swing (-$2.4B YoY), signaling aggressive investment. A major portfolio restructuring is underway as Kontoor Brands sells its Lee® business for up to $1B to focus on higher-growth brands, a move that will likely reshape the apparel landscape. Capital allocation is a key theme, with Kraft Heinz aggressively managing its balance sheet via a $1.1B debt tender, while Constellation Brands bolsters its board with top marketing talent from McDonald's. Insider activity is limited in this batch, but the Gabelli Dividend & Income Trust's proxy fight with Saba Capital Management highlights a broader activist push in closed-end funds, with performance data showing GDV up 29% in the last twelve months. Overall, the sector shows strong top-line growth for dominant players, but margin pressures from fuel costs and investment cycles are evident, creating a 'winners-take-most' dynamic.

19 high priority 31 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — May 21, 2026

The 50 filings from S&P 500 Industrials reveal a sector bifurcated between resilient capital-goods players and deeply distressed small-caps. Deere & Co. posted a 5% revenue increase but saw its Production & Precision Agriculture segment profit plunge 39%, while Advanced Drainage Systems reported 9.9% top-line growth but a 54% GAAP net income collapse due to acquisition costs. The most transformative event is the $69B AvalonBay/Equity Residential merger of equals, creating a multifamily REIT behemoth with $125M in net synergies. Capital allocation is defensive: Tractor Supply secured a new credit facility, Barnwell raised $3.4M via equity issuance, and Unity Bancorp maintained a $0.16 dividend. A wave of 14 Puerto Rico closed-end funds announced strategic reviews to convert to open-end structures, signaling a structural shift in that market. Insider activity is sparse but notable, with Nocopi Technologies insiders participating in a private placement alongside a transformative acquisition. The overarching theme is 'scale or die'—companies are using M&A and restructuring to navigate margin pressure while cash-strapped micro-caps like Dalrada face acute liquidity risk.

26 high priority 24 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — May 21, 2026

The S&P 500 Energy sector filings today reveal a bifurcated landscape: aggressive capital deployment into upstream acreage and midstream consolidation, contrasted with mixed operational performance and margin pressure. Devon Energy's $2.6B Delaware Basin acquisition at $161,500/acre signals strong conviction in Permian economics, while Baker Hughes' EC filing for the Chart Industries merger (expected July 2026) advances a transformative midstream deal. However, Copart's Q3 FY2026 results show domestic revenue stagnation (U.S. service revenues -2.1% YoY for nine months) offset by international strength (+11.4% YoY), and ONEOK's annual meeting confirmed stable governance. EOG Resources' doubling of its buyback authorization to $20B (with $2.9B remaining) underscores sector-wide capital return momentum, though Nocopi's dilutive $2.65M acquisition (500K shares issued) highlights small-cap execution risk. Insider activity is muted across filings, but the absence of selling in large caps is notable. Portfolio-level trends show capital discipline (buybacks > dividends) and a pivot toward high-return basin acreage, while margin compression in services (Copart U.S. operating income -0.5% YoY) warrants monitoring.

2 high priority 7 medium 9 total filings